Evidence map›Paper›PMID 40065473›Full record

ReviewTropical medicine and health2025

Global partnerships in combating tropical diseases: assessing the impact of a U.S. withdrawal from the WHO.

Ikponmwosa Jude Ogieuhi, Victor Oluwatomiwa Ajekiigbe, Stephen Olaide Aremu, Victory Okpujie, Peace Uchechi Bassey, Adetola Emmanuel Babalola, Pelumi Gbolagade-Jonathan, Chidera Stanley Anthony, Ifeoluwa Sandra Bakare

Abstract readReview
In one paragraph

Review in Tropical medicine and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ikponmwosa Jude OgieuhiSiberian State Medical University, Tomsk, Russia.
Victor Oluwatomiwa AjekiigbeLadoke Akintola University of Technology, Ogbomosho, Nigeria.
Stephen Olaide AremuGlobal Health and Infectious Disease Control Institute, Nasarawa State University, Keffi, Nasarawa, Nigeria.
Victory OkpujieUniversity of Benin, Ugbowo, Nigeria.
Peace Uchechi BasseySchool of Public Health, University of Port Harcourt, Port Harcourt, Nigeria.
Adetola Emmanuel BabalolaKornberg School of Dentistry, Temple University, Philadelphia, USA.
Pelumi Gbolagade-JonathanUniversity of Ibadan, Ibadan, Nigeria.
Chidera Stanley AnthonyUniversity of Calabar, Calabar, Nigeria.
Ifeoluwa Sandra BakareTernopil State Medical University, Ternopil, Ukraine. Bakaresandra9@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnnually, tropical diseases are a major cause of mortality; for instance, in 2019, neglected tropical diseases (NTDs) caused 150,000 deaths and 19 million DALYs, with sub-Saharan Africa bearing over half the burden and the other concentrations in Asia and South America. Their impact, though significant, is lower than ischemic heart disease and respiratory infections. The World Health Organization is critical in combating these tropical diseases through surveillance, information campaigns and health promotion. Through international collaborations and initiatives, tropical diseases have been relatively mitigated; for example, global initiatives eradicated smallpox (1980), cut polio cases by 99% (1988-2022), and reduced Guinea worm cases from 3.5 million (1986) to 14 (2023), while NTD prevalence dropped significantly from 1990 to 2020. Main body The potential departure of a major player like the United States, the largest WHO donor, which contributed $1.284 billion (20% of its budget) in 2022-2023, surpassing the Gates Foundation ($689M), Gavi ($500M), and the EU ($412M), and its potential withdrawal threatens WHO's financial stability, jeopardizing emergency responses, disease prevention, and global health initiatives, urging stakeholders to reinforce global health systems. Governments, international organizations, and private partners must work together to create strong, flexible frameworks that prioritize prevention, research, and equitable healthcare delivery. By fostering collaboration, transparency, and mutual accountability, the global health community can continue to make progress toward eliminating the burden of major tropical diseases such as malaria and Dengue fever, among others. Failure to do so could reverse hard-won gains such as the 99% reduction in polio cases since 1988, the near-eradication of Guinea worm disease (from 3.5 million cases in 1986 to 14 in 2023), and declining NTD burdens, leading to resurgence and increased mortality among vulnerable populations worldwide, with devastating consequences for millions of people throughout the world.

conclusionsThis review examines the role of countries and organizations in fighting tropical diseases, with a perspective on the potential consequences of the U.S. exit from the WHO. We also discuss the importance of cross-border collaborations in fighting tropical diseases, healthcare systems strengthening efforts, and a call to strengthen efforts through other sources of funding and collaborations.

Indexed as

AfricaCollaborationsMortalityPublic healthTropical diseasesWHO

Identifiers

PMID40065473
PMCPMC11892267

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.